At a glance
ClinicalIndex Comparison RecordN/ACompleted· 17 enrolled
Drug / intervention
mare´s milk +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Dietetic Effects of Mare's Milk in Patients With Chronic Inflammatory Bowel Diseases (IBD) - a Double Blind Placebo Controlled Cross-over Study.
In Brief
A clinical study evaluating mare´s milk and placebo drink for Ulcerative Colitis and Crohns Disease. Completed, enrolled 17 participants across 2 sites.
Detailed Summary
Mare's milk consumption could improve the well-being in patients with Crohn's disease and ulcerative colitis, respectively.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUlcerative Colitis, Crohns Disease
CountriesGermany
CollaboratorsGerman Federal Ministry of Education and Research
Timeline
N/ACompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2000
Primary CompletionFeb 2001
First PostedJul 2009
TodayJul 2026
First PostedJul 16, 2009
Enrollment StartJul 1, 2000
Primary CompletionFeb 1, 2001
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 17.0 years ago
Interventions
mare´s milkdietary
oral intake of 250 ml mare's milk first, then placebo drink daily during 8 weeks of each (cross over design)
placebo drinkother
oral intake of 250 ml placebo drink first, then mare's milk daily during 8 weeks of each (cross over design)